证券记录 · 已归档季度
RNAM
Avidity Biosciences Inc · Healthcare · Biotechnology
11被追踪持有人
0Δ持有人
25.98M持有股份
$1.19B报告持仓市值
+1新建仓位
−1清仓
动量输入（同类管理人）： 持有人广度 0.0% · 股份流向 +17.4% · 净新建仓位 0.0% — 公式
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q4 2025 | 103 | +3 | 81.99M | $5.91B | +5 | −1 |
| Q3 2025 | 15 | 0 | 78.61M | $3.43B | — | −1 |
| Q2 2025 | 13 | -1 | 64.96M | $1.84B | +1 | −2 |
| Q1 2025 | 11 | -2 | 31.61M | $933.16M | — | −2 |
| Q4 2024 | 13 | +1 | 31.55M | $918.65M | +1 | — |
| Q3 2024 | 11 | 0 | 25.98M | $1.19B | +1 | −1 |
| Q2 2024 | 11 | — | 22.12M | $903.80M | — | — |
持有人 · Q3 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 10.63M | -2.6% | $488.42M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 10.63M | -2.6% | $488.42M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 3 | Wellington Management ✦ | 7.03M | +84.9% | $322.93M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 4 | Wellington Management ✦ | 7.03M | +84.9% | $322.93M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 5 | Wellington Management ✦ | 7.03M | +84.9% | $322.93M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 6 | Wellington Management ✦ | 7.03M | +84.9% | $322.93M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 7 | Wellington Management ✦ | 7.03M | +84.9% | $322.93M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 8 | Wellington Management ✦ | 7.03M | +84.9% | $322.93M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 9 | Wellington Management ✦ | 7.03M | +84.9% | $322.93M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 10 | Wellington Management ✦ | 7.03M | +84.9% | $322.93M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 11 | Adage Capital Partners ✦ | 3.08M | -9.3% | $141.44M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 12 | Geode Capital Management ✦ (被动) | 2.59M | +14.6% | $118.77M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | Geode Capital Management ✦ (被动) | 2.59M | +14.6% | $118.77M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | D. E. Shaw & Co. ✦ | 1.11M | +50.0% | $50.92M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 15 | D. E. Shaw & Co. ✦ | 1.11M | +50.0% | $50.92M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 16 | Norges Bank ✦ (被动) | 1.05M | 新增 | $48.08M | 0.0% | New | 1 | SEC ↗ |
| 17 | Marshall Wace ✦ | 182.21K | +63.0% | $8.37M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | Renaissance Technologies ✦ | 141.90K | -62.4% | $6.52M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | Two Sigma Investments ✦ | 130.09K | -42.4% | $5.98M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 24.95K | +107.2% | $1.15M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 24.95K | +107.2% | $1.15M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 24.95K | +107.2% | $1.15M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 23 | Millennium Management ✦ | 18.54K | -85.2% | $851,358 | 0.0% | ▼ Trim | 2 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Norges Bank | $48.08M | 0.0% |
已清仓
| Citadel Advisors | $6.57M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1 持有人, 8.00K 股份, $236,160 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2024 ·
方法论 ·
通过API获取此数据